NATICK, Mass., May 17 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in Brussels, Belgium designed to help health care professionals advance the standard of patient care. The Company expects the new addition to be completed in early 2007.

The new facility will be able to host thousands of health care professionals annually and will offer medical education and skills training on the latest developments in the medical device field. Originally founded in 2000 by Guidant in Brussels, the Institute for Therapy Advancement is a leader in medical education programs that address the real-world practical needs of health care professionals and is now part of a Boston Scientific global medical education network with campuses in Tokyo, Japan, Brussels, Belgium and St. Paul, Minnesota in the United States. Boston Scientific acquired Guidant on April 21.

"From our work at the Institute for Therapy Advancement over the past five years, we have learned which type of training is important to health care professionals," said Professor Jean Marco of the Institute Pasteur in Toulouse. "This experience is a guide to building a second generation Institute that better addresses the specific needs of medical professionals at all levels."

"This new Institute for Therapy Advancement facility is a reflection of our commitment to helping physicians put into practice the latest developments and guidelines," said Jeff Goodman, Senior Vice President and President of International of Boston Scientific. "We understand that time is a scarce resource for clinicians today so the effectiveness and efficiency of continued medical education has become increasingly important."

Programs at the Institute for Therapy Advancement are designed and taught by independent physician experts. As a result, the majority of programs hosted by the Institute are CME accredited. More than 15,000 health care professionals have participated in the Institute's programs to date.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.

This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with the regulatory approval process, reimbursement policies, commercialization of new technologies, education and training of health care professionals, litigation, the Company's overall business strategy and other factors described in the Company's filings with the Securities and Exchange Commission.

  CONTACT: Milan Kofol
           508-650-8569 (Office)
           Investor Relations
           Boston Scientific Corporation

           Charles Rudnick
           508-650-8660 (Office)
           617-935-1789 (Mobile)
           Media Relations
           Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569 (Office), or
Charles Rudnick, Media Relations, +1-508-650-8660 (Office) or +1-617-935-1789
(Mobile), both of Boston Scientific Corporation

Web site: http://www.bostonscientific.com/